These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 28600705)

  • 1. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
    Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
    Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
    Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
    Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
    Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
    Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients.
    Janz TA; Momin SR; Sterba KR; Kato MG; Armeson KE; Day TA
    Am J Otolaryngol; 2019; 40(1):40-45. PubMed ID: 30322742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of post-chemoradiotherapy DWI ADC
    Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma.
    Windon MJ; D'Souza G; Waterboer T; Rooper L; Westra WH; Troy T; Pardoll D; Tan M; Yavvari S; Kiess AP; Miles B; Mydlarz WK; Ha PK; Bender N; Eisele DW; Fakhry C
    Head Neck; 2020 Aug; 42(8):1954-1962. PubMed ID: 32101350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Dave E; Su W; Gupta V; Miles B; Demicco E; Soriano T; Bakst RL
    Anticancer Res; 2017 Apr; 37(4):1847-1851. PubMed ID: 28373450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
    PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.